Overview

Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients

Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Since it is not uncertain about efficacy of combination therapy with PSK and TS-1 in gastric cancer, in this study, we compare efficacy and safety of postoperative adjuvant therapy using TS-1 or TS-1+PSK in the stage II or III gastric cancer patients.
Phase:
Phase 3
Details
Lead Sponsor:
Tokyo Metropolitan Oncology Group
Treatments:
Krestin
polysaccharide-K
Tegafur